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Protein-DNA interactions (PDIs) mediate a broad
range of functions essential for cellular differentiation,
function, and survival. However, it is still a daunt-
ing task to comprehensively identify and profile
sequence-specific PDIs in complex genomes. Here,
we have used a combined bioinformatics and protein
microarray-based strategy to systematically charac-
terize the human protein-DNA interactome.We identi-
fied17,718PDIsbetween460DNAmotifs predicted to
regulate transcription and 4,191 human proteins of
various functional classes. Among them, we recov-
ered many known PDIs for transcription factors
(TFs). We identified a large number of unanticipated
PDIs for known TFs, as well as for previously unchar-
acterized TFs. We also found that over three hundred
unconventional DNA-binding proteins (uDBPs)–which
includeRNA-bindingproteins,mitochondrial proteins,
andprotein kinases–showed sequence-specific PDIs.
One such uDBP, ERK2, acts as a transcriptional
repressor for interferon gamma-induced genes, sug-
gesting important biological roles for such proteins.
INTRODUCTION
A major challenge in the postgenome era is decoding the func-
tional elements in the human genome. Aided by the sequencing
of multiple genomes, computational approaches have identified
a large number of evolutionarily conserved DNA elements that
include many previously characterized cis-regulatory elements
(Xie et al., 2005; Xie et al., 2007). Additional studies have identified610 Cell 139, 610–622, October 30, 2009 ª2009 Elsevier Inc.DNAmotifs that are highly enriched in promoters of coexpressed
genes (Elemento et al., 2007; Elemento and Tavazoie, 2005; Yu
et al., 2006). However, theproteins that recognize theseelements
cannot be reliably predicted computationally, and the target pref-
erences of only a small minority of DNA-binding proteins have
been characterized. Therefore, the identification of interaction
networks among the functional elements is the next major step
following the identification of the parts list in the human genome.
Protein-DNA interactions (PDIs) are perhaps the most impor-
tant regulatory interactions involving these functional elements.
The most intensively studied subset of PDIs is those between
transcription factors (TFs) and their specific DNA target
sequences. There are over 1,400 known and predicted human
TFs, which fall into multiple subfamilies (Kummerfeld and Teich-
mann, 2006; Messina et al., 2004). Aside from the interactions
between conventional TFs and DNA, the larger set of potential
DNA-binding proteins has not been extensively explored.
Some proteins that lack any known DNA-binding domains
have been found to bind specific DNA sequences (Boggon
et al., 1999; Kipreos and Wang, 1992). For instance, Arg5,6,
a yeast protein which has traditionally been regarded as a meta-
bolic enzyme with no additional biological functions, recognizes
specific DNA sequences and regulates the transcription of genes
in the mitochondria (Hall et al., 2004). In general, most proteins
that display sequence-specific DNAbinding are thought to act as
TFs (Teichmann and Babu, 2004); however, some sequence-
specific DNA-binding proteins play central roles in such
processes as DNA replication, DNA repair, and chromosome
dynamics, and are not thought to act as TFs (Petukhova et al.,
2005; Tokai-Nishizumi et al., 2005; Zhu et al., 2003).
In the past, biochemical approaches have been used to
characterize PDIs, but such approaches are generally laborious
and slow. Recent years have witnessed the development of
large-scale, unbiased technologies to characterize PDIs. These
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Figure 1. Overall Experimental Design for Analyzing Human PDIs
(A) Sources of the DNA motifs used for probe construction.
(B) Distribution of human proteins selected for protein microarray construction. Some proteins belong tomore than one functional class and thus may be counted
more than once.
(C) Overall scheme used to identify PDIs in humans using DNA probe binding to protein microarrays.approaches can be either gene-centered, in which an individual
protein is used to identify target sequences, or protein-centered,
in which a DNA sequence is used to screen for uncharacterized
DNA-bindingproteins.Several recent large-scale, gene-centered
approaches have employed the double-stranded DNA microar-
rays, the bacterial one-hybrid system and the yeast one-hybrid
system to characterize PDIs in mice, Drosophila, and C. elegans,
respectively (Berger et al., 2008; Deplancke et al., 2006; Noyes
et al., 2008). Conversely, protein microarrays have been used
both to characterize PDI networks (Ho et al., 2006) and to identify
unconventional DNA-binding proteins in yeast (Hall et al., 2004).
In the present study, by using a microarray of 4,191 nonredun-
dant human proteins comprising of known and predicted
TFs, as well as representative proteins from other functional
classes, we have systematically identified proteins that selec-
tively bind DNA sequences that are either highly evolutionarily
conserved or found in the promoters of coexpressed genes.
We were able to extensively identify PDIs for known as well as
previously uncharacterized human TFs, and we unexpectedly
also found thatmany proteins of other functional classes showed
sequence-specific PDIs. We further characterized the DNA
binding activity of ERK2, one of these unconventional DNA-
binding proteins, using in vitro and in vivo assays and demon-
strated that ERK2 acts as a transcriptional repressor regulating
interferon gamma signaling in mammalian cells.
RESULTS
Experimental Design
We employed a combined approach to systematically identify
proteins that can specifically recognize predicted functionalhuman DNA elements (Figure 1). First, we obtained 752 pre-
dicted DNA motifs from previously published studies (Elemento
et al., 2007; Elemento and Tavazoie, 2005; Xie et al., 2005; Xie
et al., 2007). Second, we used algorithms generated in our labora-
tories to identify different sets of DNA elements enriched in
promoter sequences of tissue-specific genes (see the Supple-
mental Experimental Procedures available online). Third, we
retrieved 60 sequences from the TRANSFAC database corre-
sponding to experimentally-verified binding sites for known TFs
(Wingender et al., 1996). After combining these three sources,
weremovedhighlysimilarmotif sequencesusingaclusteringalgo-
rithm to produce 460 sequence-diverse DNA motifs with lengths
ranging from 6–34 base pairs (Figure 1A, Supplemental Experi-
mental Procedures, Figures S1 and S2, and Table S1). Double-
stranded DNA (dsDNA) probes based on these sequences were
then synthesized as previously described (Ho et al., 2006).
We next assembled a list of proteins that are likely to recognize
these predicted DNAmotifs (Table S2 and Supplemental Experi-
mental Procedures). Theproteinscanbecategorized intomultiple
functional classes (Figure 1B) (1) 1370 known and predicted TFs,
representing around 80% of annotated human TFs (Ashburner
et al., 2000); (2)proteinsknown tobind tonucleicacidsbutwithout
known sequence-specific PDIs, such as RNA-binding proteins,
chromatin-associated proteins, and DNA repair enzymes; (3)
proteins that regulate transcription but are not known to directly
bind DNA, such as transcriptional coregulators; (4) mitochon-
dria-encoded and -targeted proteins and protein kinases, for
whichpreviousexperimental evidenceshadsuggested that these
classes of proteinmay regulate gene expression (Hall et al., 2004;
Pokholok et al., 2006); and (5) an assortment of proteins from
a broad range of other functional classes (Table S3).Cell 139, 610–622, October 30, 2009 ª2009 Elsevier Inc. 611
Human ORFs on this list were selected from the Invitrogen
Ultimate ORF collection (Liang et al., 2004) or subcloned in our
own laboratories. Using Gateway site-specific recombination
(Hartley et al., 2000), ORFs were shuttled to a yeast expression
vector that produces N-terminal GST fusions of each protein,
and purified from yeast using a previously described strategy
(Zhu et al., 2001). To ensure that recombinant proteins were
of good quality, we performed immunoblot analysis using
anti-GST antibodies, along with silver staining on a randomly
selected subset of 200 proteins. Detectable levels of full-length
forms of over 90% of the proteins were observed using both
methods. Silver staining confirmed the absence of detectable
contaminating yeast proteins after purification (Figure S3).
Following printing onto nitrocellulose-coated slides (FAST), the
complete protein array was probed multiple times with anti-
GST antibodies, and more than 98% of the spots produced
a signal above background (Figure S4). Pair-wise correlation
coefficients of signal intensities ranged from 0.90–0.95 between
these slides, illustrating consistency in the array quality.
Data Quality Assessment
To assess the specificity and sensitivity of our approach, we first
probed the protein microarrays with three DNA motifs corre-
sponding to consensus-binding sequences for three TFs. These
motifs produced highly specific signals, binding selectively to
their target proteins with minimal background (Figure 2A). We
further tested the specificity of these interactions by probing
the array with mutant motifs and observed that they no longer
showed specific PDIs (Figure 2A). To eliminate nonspecific
PDIs, we also probed the array with Cy5-labeled oligos corre-
sponding to the T7 primer that was used to generate the dsDNA
probes. We identified 134 proteins that bound this probe
and excluded them from further analysis. On the basis of our
earlier observation that bovine histones H3 and H4 bound
intensely and nonspecifically to every DNA probe tested, we
printed these proteins multiple times on each array as landmarks
for orientation and as positive controls for hybridization (Fig-
ure 2B). Experimental variability for microarray hybridization
was determined by conducting replicate hybridizations of the
same probe to four slides. Pair-wise correlation coefficients of
signal intensities ranged from 0.68–0.84 for the four slides, with
greater consistency for strong signal intensities (Figure S5). On
the basis of these control experiments, we concluded that our
approach could detect known PDIs sensitively, specifically,
and reproducibly.
Global Properties of Observed PDIs
We next used the protein array to analyze PDIs for all of the
designed dsDNA motif probes. DNA-binding signals were
acquired, analyzed, and normalized using the procedures
described in Supplemental Experimental Procedures. From
histogram analysis of each hybridization reaction, we observed
that a small number of proteins showed strong positive signals
with signal intensities many standard deviations (SD) above
background, while the vast majority of proteins produced only
small background levels of intensity (Figures 2A, 2B, and S6).
To increase our confidence in our PDI identification, we applied
a stringent cut-off value of 6 SD above background (Table S4).612 Cell 139, 610–622, October 30, 2009 ª2009 Elsevier Inc.A total of 17,718 PDIs were detected, with amedian number of
30 proteins interacting with each DNA motif probe. Only a single
motif did not bind specifically to any of the proteins on the array
(Figure 2C). Motif length did not correlate with either the binding
intensity or the number of binding proteins observed with a given
motif probe (Figure S7). Many proteins on the array bound to only
a few probes, while only relatively few proteins bound to a large
fraction of probes, a behavior that followed a power-law distribu-
tion (Figure 2D). In fact, more than 85.7% of the proteins bound
to fewer than 30 of the motifs, confirming that most of the
observed PDIs are sequence-specific. For the remaining anal-
ysis performed in this study, we focus on only those proteins
that fall into this class. It is notable that proteins from different
functional classes showed different levels of sequence binding
specificity, where RNA-binding proteins have the least sequence
specific binding (Figure S8).
TF Binding Specificity
To comprehensively characterize sequence-specificity of the
human TFs, we first attempted to identify consensus sequences
(logos) that were preferentially bound by individual TFs. We were
able toextractsignificantconsensussequences for201TFs (Table
S5). These often show considerable overlap with those extracted
from TRANSFAC, indicating that our approach can recover reli-
able consensus sequences using the test motifs (Figure 3A and
Table S6). Among all consensus sequences, there are 166 for
TFs which have no known binding sites listed in TRANSFAC.
Our analysis considerably expands our knowledge of binding
specificity of human TFs, almost doubling the number of human
TFs for which consensus binding sites have been identified.
We next clustered the TFs based on the similarity of their
consensus sequences (Figure 3B). Some TFs with certain DNA-
binding domains (e.g., ETS, homeodomain and bHLH) showed
more conserved DNA binding specificity. For example, in a clade
all but one TF contain the homeodomain and recognize a TAAT
consensus sequence (Figure 3B). Interestingly, we found that
while some TFs in the same subfamilies showed DNA binding
profiles that were distinct from other members of that gene
family (e.g., zf-C2H2), many TFs with highly divergent protein
sequences bound to highly similar or even identical target DNA
sequences (Figure 3B and Table S7). This observation suggests
that global primary protein sequence identity does not neces-
sarily correlate with DNA binding specificity.
Finally, we examined the PDIs on the TF subfamily level. We
extracted familial logos for the 12 major TF subfamilies (Fig-
ure 3C). When compared to the known familial logos from the
TRANSFAC and JASPAR databases (Sandelin et al., 2004;
Wingender et al., 1996), our analysis identified 8 of the 12 previ-
ously reported familial logos. Furthermore, multiple logos were
identified for five subfamilies, suggesting that a considerable
diversity of DNA binding specificity can be found in members
of a given TF subfamily, as has recently been shown for mouse
and Drosophila homeodomain proteins (Berger et al., 2008;
Noyes et al., 2008).
The zf-C2H2 subfamily illustrates the power of our approach.
This subfamily contains over 400 members, but no familial logos
have been previously reported because of the limited number of
confirmed PDIs. With the large number of PDIs characterized in
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Figure 2. Human Protein-DNA Interactions Detected via Protein Microarrays
(A) Binding specificity of three previously characterized PDIs. Three Cy5-labeled, known dsDNAmotifs are separately probed to the protein microarrays and can
be specifically recognized by their known TFs, whereas the mutant motifs can no longer bind to their known TFs. Mutated positions are indicated in red.
(B) A typical example of a DNA-binding assay. The DNAmotif selectively recognizes RBM38, a predicted RNA-binding protein (inset). Histones H3 and H4, which
serve as landmarks and positive controls, are printed in duplicate at a corner of each of the 48 printed blocks.
(C) Histogram showing the number of proteins on the array that were bound by each DNA probe tested.
(D) Histogram showing the number of DNA probes bound by each protein on the array.this study, we identified six significant logos. For the homeodo-
main subfamily, we identified not only the canonical consensus
site, but also the atypical site recently reported for the TGIF
(Drosophila) and Meis1 (mouse) groups (Berger et al., 2008;
Noyes et al., 2008). On the other hand, only a single familial
logo was identified for the NHR, ETS, and RHD subfamilies.
These logos closely matched the reported familial logo for
each subfamily. Finally, in the case of the Forkhead, IRF, MH1,
and Myb subfamilies, we identified familial logos that did not
closely resemble the reported ones.To confirm the specificity of PDIs identified for TFs, we carried
out electrophoretic mobility shift assays (EMSA) to test the PDIs
for 22 annotated and nine predicted TFs. Notably, 27 of the
31 TFs tested (87.1%) demonstrated specific PDIs, indicating
a low false-positive rate for the PDIs identified by protein micro-
array analysis (Table S8). Figure S9 shows representative exam-
ples of 9 of the subfamilies for which familial logos were identi-
fied, along with an example of a predicted TF that does
not belong to any of these subfamilies. The proteins used in
EMSA were tested with silver staining to eliminate the possibilityCell 139, 610–622, October 30, 2009 ª2009 Elsevier Inc. 613
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Figure 3. PDIs for Known and Predicted TFs
(A) Comparison between TF-binding logos identified in this study and those listed in TRANSFAC.
(B) Clustering of TFs based on similarity of their DNA logos identified in this study. Only TFs containing known DNA-binding domains were used to construct the
cluster. Seven DNA-binding domains are explicitly indicated in the cluster and the other domains are indicated as ‘‘Other.’’
(C) Familial logos identified for the 12 TF subfamilies. Known logos were obtained from JASPAR database (Sandelin et al., 2004). Familial logos recovered in this
study that are similar to the known familial logos are outlined in red. Logos validated with EMSA assays are outlined in blue.of yeast protein contamination (Figure S10). For the four sub-
families (Forkhead, IRF, MH1, and Myb) that did not match
the known logos, we were able to validate their logos using
EMSA.614 Cell 139, 610–622, October 30, 2009 ª2009 Elsevier Inc.Identification of Unconventional DNA-Binding Proteins
Surprisingly, we were able to detect many PDIs between DNA
motifs and proteins of other functional classes not previously
known to show sequence-specific PDIs. We also extracted
consensus sequences for individual unconventional DNA-
binding proteins (uDBPs) (Table S9) as well as significant familial
logos for each functional class (Figure S11).
For each class of proteins queried, we observed different
percentages of proteins showing DNA binding activity (Table 1).
The percentages of proteins in different classes that showed
DNA binding activity varied greatly—from 4.3% of the protein
kinases to 29.7% of the RNA-binding proteins. As a comparison,
41.2% of the annotated TFs showed PDIs, the highest among all
protein classes tested. In total, we identified 634 unique uDBPs
(Table 1, complete set; note that some proteins belong to
multiple functional classes, so that the number of proteins in
each functional class listed on Table 1 adds up to more than
this total number). This represents 22.4% of all the 2820 non-
TF proteins tested, implying that an unexpectedly large fraction
of human proteins possess sequence-specific DNA binding
activity.
We noticed that some of these proteins are not known to be
located in the nucleus, implying that some observed unconven-
tional PDIs might not occur in vivo. To increase the confidence,
we further refined this data set to consider only proteins
annotated as having nuclear localization in the GO database
(Table 1, high-confidence set). Since mitochondrial transcription
is actively regulated, all PDIs annotated in GO as showing
Table 1. Statistics of Human PDIs Detected in This Study
Protein Class
Total Number
of Proteins
DNA-Binding Proteins
Complete
Seta
High-Confidence
Seta
Number
Ratio
(%) Number
Ratio
(%)
Known TFs 1106 456 41.2 382 34.5
Predicted TFs 264 37 14.0 20 7.6
Protein kinases 329 14 4.3 7 2.1
Chromatin-
associated
proteins
287 73 25.4 63 22.0
RNA-binding
proteins
698 207 29.7 124 17.8
Transcriptional
coregulators
238 43 18.1 25 10.5
Other nucleic
acid-binding
proteins
257 50 19.5 38 14.8
DNA repair &
replication
146 50 34.2 42 28.8
Mitochondrial
proteins
652 97 14.9 64 9.9
All other
categories
589 132 22.4 42 7.1
aComplete set of DNA-binding proteins denotes proteins showing DNA
binding activity on the protein microarrays. High-confidence set denotes
proteins in the complete set which are also annotated as nuclear-local-
ized proteins in GO database, expect for mitochondrial proteins, whose
cellular localization is annotated as either nuclear and/or mitochondrial
in GO.either nuclear or mitochondrial localization were considered
high-confidence. Filtering our initial results in this manner, we
obtained 367 unique uDBPs (the high-confidence set, Table 1
and Figure 4B).
Validation of uDBPs
We first used EMSA assays to confirm direct binding of repre-
sentative uDBPs to the corresponding DNA motifs in vitro.
Over 91% (41/45) of the tested uDBPs showed direct PDIs
with the corresponding DNA motifs identified from the protein
microarray data (Figure 4A, Table S10). To experimentally vali-
date the calculated familial logos, we designed mutant DNA
sequences with differing sequences at two conserved nucleo-
tide positions. Of the 13 tested proteins, 12 (92.3%) showed
significant decreases in PDIs with the mutant motifs. Proteins
demonstrating sequence-specific PDIs in this assay came from
diverse functional categories, including mitochondrial-targeted
proteins, RNA-binding proteins, and protein kinases (Figures
4A and S12). Furthermore, no contaminating yeast proteins
were observed following silver-staining analysis of the purified
recombinant proteins that were used for EMSA, implying that
any observed PDIs are highly unlikely to result from the presence
of any contaminating yeast TFs (Figure S10).
It is notable that the EMSA assays confirmed highly sequence-
specific PDIs for several RNA-binding proteins, many of which
were believed to bind RNA and/or DNA molecules indiscrimin-
ately. To further validate their binding specificity, we performed
additional EMSA assays with single-stranded DNA (ssDNA) as
competitors for two representative RNA-binding proteins. The
sequence-specific PDIs showed no apparent difference with or
without competition from ssDNA (Figure S13), confirming that
observed specific PDIs for these RNA-binding proteins indeed
result from binding to dsDNA. Taken together, these results indi-
cate that the majority of the uDBPs identified in this study can
indeed interact with DNA motifs directly and specifically.
Many uDBPs Associate with DNA In Vivo
The most surprising result to us is the observation of sequence-
specific PDIs for sugar and protein kinases. To determine
whether these uDBPs associate with DNA in vivo, we selected
antibodies against phosphoenolpyruvate carboxykinase 2
(PCK2) and mitogen-activated protein kinase 1 (ERK2/MAPK1)
to perform chromatin-immunoprecipitation (ChIP). Using
primers designed to flank genomic-binding sites for these
proteins predicted from our protein microarray PDI data, we ob-
tained positive PCR products for both proteins (Figures 5D and
S14), indicating that they do indeed associate with these pre-
dicted target sequences in vivo. We next conducted a thorough
literature search and found that an additional 12 of the 367
uDBPs identified in this study have been shown to associate
with DNA in vivo using ChIP (Table S11), although these previous
studies had interpreted these data to indicate that these proteins
did not directly bind DNA. More importantly, we found that
ChIPed DNA products in every case included sequences that
match the predicted consensus DNA-binding sites for these
uDBPs. Taken together, a total of 14 uDBPs are associated
in vivo with DNA fragments that contain our predicted DNA
logos.Cell 139, 610–622, October 30, 2009 ª2009 Elsevier Inc. 615
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Global Classification of uDBPs
Given the existence of this group of uDBPs, we set out to classify
and organize these proteins. We assessed protein relatedness
on the basis of the DNA motif sequences to which the proteins
bound. DNA-binding profiles were constructed for each protein
to include the binding intensity of the protein to each of the
460 distinct DNA-binding motifs (Supplemental Experimental
Procedures). A hierarchical tree was then built based only on
the similarity of the binding profiles of these unconventional
DNA-binding proteins (Figure 4B). Two disparate trends were
observed: On the one hand, in some clades there was a clear
enrichment of proteins traditionally known to be part of a specific
functional class. For example, two clades (Figure 4B, blue and
green shading) were significantly over-represented for mito-
chondria proteins (p < 4.78e-11) and RNA-binding proteins
(p < 4.15e-9), respectively. Another interesting example is that
eukaryotic translation elongation factor 1 alpha 1 (EEF1A1) and
delta (EEF1D), which belong to the translational elongation
complex but share no sequence homology, were found to recog-
nize similar DNAmotif sequences. Such clustering indicates that
some proteins that are similar either in terms of sequence
homology or functional annotation may have similar DNA-
binding characteristics. On the other hand, a mixture of function-
ally divergent proteins without sequence homology were also
observed to share similar DNA-binding motifs in some clades
(Figures 4B and 4C), indicating that these proteins of highly
divergent structure and function may cooperate to control the
same DNA-binding targets.
ERK2 Acts as a Transcriptional Repressor
As demonstrated above, many uDBPs directly and specifically
bind DNA in vitro and 14 of them are found to associate with
DNA in vivo. Therefore, we predicted that these uDBPs might
play a physiological role in transcriptional regulation in vivo.
We decided to focus on in-depth characterization of this prop-
erty in ERK2, an extensively studied protein that is known to
be involved in a variety of biological processes, including prolif-
eration, differentiation, and development.
Our proteinmicroarray-based PDI analysis revealed that ERK2
can bind to a G/CAAAG/C consensus sequence. We investi-
gated this directly using EMSA analysis using both wild-type
oligonucleotides matching the consensus site and mutant
probes that departed from this consensus. We found that this
binding is sequence-specific, since mutant oligonucleotides
no longer showed binding activity (Figure 5A). Silver-staining
analysis of ERK2 showed that no contaminating yeast proteins
were observed (Figure S10). In addition, we performed EMSA
assays with ERK2 protein purified from E. coli and still observedthe sequence-specific PDI, further ruling out any possible
contamination from yeast TFs (Figure S15).
To determine whether ERK2 could act as a transcriptional
regulator in vivo through sequence-specific DNA binding, we
next employedcell-based luciferase analysis. The corresponding
wild-type and mutant motif sequences were cloned upstream of
a minimal promoter in a luciferase reporter construct. We found
that ERK2 tested with the wild-type motif sequence showed
repression of luciferase expression in adose-dependentmanner,
but showed little or no change in luciferase expression when
assayed with the mutant motif, which did not bind to ERK2
protein in the EMSA assay (Figure 5B).
To identify targets of ERK2 and thereby gain clues to its func-
tion, we compared the gene-expression profiles of HeLa cells to
those of the cells in which ERK2 is knocked down using siRNA
(Huang et al., 2008). Because ERK2 showed a dose-dependent
repression of luciferase activity in the assays described above,
we collected the promoter sequences of 82 genes that showed
at least a two-fold upregulation of expression following siRNA-
mediated knockdown of ERK2 when compared to the control.
Application of an in silico motif discovery algorithm to these
sequences revealed a similar consensus sequence (GAAAC) to
that determined by the protein microarray analysis (Figure 5C
and Supplemental Experimental Procedures). In fact, the pro-
moter regions of 78 of the 82 genes contained a total of 270
GAAAC sites, a clear indication of significant enrichment for
these upregulated genes (p = 1.5e-9). The distribution of the
ERK2-binding sites relative to the transcription start site showed
a sharp peak around 90 bp, a typical distribution for many TFs
(Figure 5C). ERK2 consensus sequences were not enriched
in the promoter sequences of downregulated genes in ERK2
siRNA-treated cells, consistent with our observation that ERK2
represses gene expression in luciferase assays (Figure 5B).
To determine whether ERK2 binds in vivo to the promoters of
any of these genes whose expression is upregulated in HeLa
cells lacking ERK2 and that contain GAAAC logos upstream,
21 of these genes were tested for ERK2 binding by using ChIP.
Eleven of 21 genes (52.3%) showed higher levels of immunopre-
cipitation with the anti-ERK2 antibody relative to controls (Fig-
ure 5D). Such enrichment was not observed for any of the six
downregulated or the six unaffected genes tested (Figure S16).
Thus, ERK2 associates with GAAAC sequences in vivo to regu-
late expression of a large number of genes.
DNA Binding Activity of ERK2 Is Independent
of Kinase Activity
Because the protein kinase activity of ERK2 has been well
studied, it is possible that its DNA binding activity serves aFigure 4. DNA Binding Specificity of uDBPs
(A) Validation of unconventional PDIs with EMSA analysis. Representative examples are shown. Consensus sites identified in the current study for different
proteins are boxed and underlined in the DNA motif sequences used for the EMSA analysis. Mutated positions are indicated in red in motif sequences used
for EMSA and underscored with red dots in the predicted consensus sequences.
(B) Clustering of uDBPs based on target sequence similarity. Proteins of different function classes are color-coded. Branches highlighted in green and blue are
enriched for RNA-binding and mitochondrial-targeted proteins, respectively. Asterisks indicate that multiple proteins bind to identical target sequences; in this
case, a single representative protein is shown (see Table S12 for detail). The arrow indicates an example of two proteins that interact as part of a protein complex
but do not share protein sequence homology.
(C) Magnified view of the orange branch in (B), where the consensus sequences for each sub-branch are shown.Cell 139, 610–622, October 30, 2009 ª2009 Elsevier Inc. 617
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distinct cellular function. To explore the possibility, we examined
the 82 upregulated genes for potential functional enrichment.
These genes are enriched for proteins involved in response to
biotic stimuli (p = 1.0e-16) and to viral infection (p = 1.0e-24)
(Figure 5E). Furthermore, by analyzing the results of our ChIP-
chip analysis for ERK2, we discovered a similar consensus
sequence and a functional enrichment for response to biotic
stimuli (p = 0.03) and response to bacterial infection (p = 0.02)
(Figure 5E). These functions are not known for ERK2 in previous
studies. In contrast, we found that the 53 confirmed substrates
of ERK2 (Diella et al., 2008) are not enriched for the same
functions (Figure S17). Thus, it is very likely that sequence-
specific DNA binding activity of ERK2 is independent of its
kinase activity.
To examine the structural basis of this hypothesis, we
analyzed the crystal structure of ERK2 and identified one
surface patch as a potential DNA-binding domain, which is
comprised of three clusters of positively charged residues close
to the C terminus at considerable distance from the ATP-binding
pocket and the substrate groove (Figure 5F). Using site-directed
mutagenesis, we investigated whether these residues might be
required for sequence-specific DNA binding by ERK2. We found
that mutations in DBD3 and DBD4 completely abolished
sequence-specific DNA binding by ERK2 using EMSA analysis,
indicating that K259 and R261 are the two key residues required
for its DNA binding activity (Figure 5G). In contrast, the kinase-
dead mutant (K54R) did not show any effect on DNA binding
(Robinson et al., 1996). We further confirmed that the kinase
activity of ERK2 was not essential for DNA binding by perform-
ing EMSA analysis with purified ERK2 proteins coexpressed
with MEK1 in E. coli. We observed that DNA binding was unaf-
fected by the presence of staurosporine, a kinase inhibitor
(Figure S15).ERK2 Directly Represses Expression of Interferon
Gamma-Induced Genes via DNA Binding Activity
Finally, we set out to determine the physiological function of the
DNA binding activity of ERK2. Interestingly, nine of the eleven
genes whose promoters could be ChIPed with the anti-ERK2
antibody in HeLa cells are known to be induced by interferon.
Furthermore, previous studies have shown that a transcription
factor, CCAAT/enhancer-binding protein-b (C/EBP-b), binds to
a so-called GATE element in the proximal promoters of one of
these genes, IRF9, and activates its transcription upon interferon
gamma (IFNg) stimulation (Roy et al., 2000). We found that the
consensus site for ERK2 is embedded in GATE element. These
evidences suggest that ERK2might be involved in IFNg signaling
via its DNA binding activity.
To test specific interactions between GATE element and the
identified DNA-binding domain in ERK2, we conducted lucif-
erase analysis in transfected HeLa cells, using a wild-type
GATE element reporter and a mutant element that lacks the
consensus ERK2-binding site (Weihua et al., 1997). We find
that cotransfection of the siRNA-resistant wild-type ERK2, along
with siRNAs directed against endogenous ERK2, did not result in
a significant difference in luciferase expression compared to
controls when a wild-type GATE element reporter construct is
used (Figure 5H). However, the DNA-binding-deficient mutant
of ERK2 led to substantially upregulated reporter expression
when cotransfected with ERK2-targeted siRNA. In contrast,
kinase-dead mutants of ERK2 efficiently repressed reporter
expression. Neither wild-type nor mutant proteins showed any
effect on the activity of the mutant GATE element reporter
when overexpressed (Figure 5H). These results clearly demon-
strated that ERK2 specifically and directly represses expression
of the luciferase reporter genes driven by canonical GATE
element via its DNA-binding domain in vivo.Figure 5. ERK2 as a Transcriptional Repressor
(A) Validation of ERK2-DNA interaction with EMSA analysis. Mutated positions are indicated in red in motif sequences used for EMSA.
(B) Dose-dependent transcriptional repression by ERK2 using cell-based luciferase assays. Four tandem repeats of the wild-type (WT) motif shown to complex
with ERK2 were cloned into pTK-Luc vector and cotransfected into GT1-7 cells with varying amount of plasmids that expressed ERK2. The mutant motif that
abolished gel-shifting also abolished dose-dependent transcriptional repression by ERK2. Error bars represent ± SD of three independent experiments. The
same error measurement is also applied to the experiments in panels (H, I, and J).
(C) Positioning distribution of ERK2-binding sites in promoters. Application of an in silico motif discovery algorithm to the promoter regions of 82 upregulated
genes in a ERK2 knockdown experiment revealed a similar consensus sequence (inset) to that determined by the protein microarray analysis panel (A). The pro-
moter region extends from700 to 300 bp relative to the transcription start site (TSS). The red dashed line shows the relative position of 1000 random 5-mer DNA
sequences to the TSS.
(D) In vivo validation of ERK2 and DNA interactions using ChIP coupled with PCR analysis. An anti-ERK2 monoclonal antibody was used to ChIP the endogenous
ERK2 proteins in HeLa cells. Specific primer pairs were designed to PCR-amplify the promoter regions of the predicted targets of ERK2. Mouse IgG was used as
a negative control for immunoprecipitation. Of the 21 upregulated genes assessed, 11 (52.3%) showed higher levels of immunoprecipitation with the anti-ERK2
antibody than with the IgG control.
(E) Comparison of consensus sites and enriched GO terms in ERK2 knockdown and ChIP-chip experiments.
(F) Structural analysis for DNA-binding domain in ERK2. Calculated using PyMol, the electrostatics surface potential of ERK2 is color-coded. A surface patch
(residues 259–277) comprised of three positively charged clusters are indicated with the amino acid sequence showing above. The ATP-binding pocket is
also shown.
(G) Mapping the DNA-binding domain in ERK2. Five mutant forms of ERK2 were constructed and the corresponding proteins were purified. As determined with
EMSA analysis, mutations in DNA-binding-deficient (DBD) mutants 3 and 4 completely abolished the DNA binding activity, indicating that K259 and R261 are
required. In contrast, K54R mutation (kinase-dead) did not affect the DNA binding activity, indicating that the two activities are independent. The DNA sequence
used in the EMSA assay is also shown.
(H) Specific interactions between GATE element and the DNA-binding domain in ERK2. Using a previously reported luciferase reporter system (Weihua et al.,
1997), the effects of overexpressing ERK2 in various mutant forms are monitored in cells that the endogenous ERK2 is knocked down.
(I) Regulation of IFNg-induced gene expression by the DNA binding activity of ERK2. Changes in IRF9 and OAS1 expression are normalized to those in negative
control cells.
(J) Dynamics of promoter occupancy by ERK2 in reverse correlation to mRNA expression levels of IRF9 and OAS1 after IFNg treatment.Cell 139, 610–622, October 30, 2009 ª2009 Elsevier Inc. 619
To further confirm the transcriptional repressor activity of
ERK2 against chromosomal genes, we monitored gene expres-
sion level of two known IFNg-induced genes, IRF9 andOAS1, by
overexpressing different mutant forms of ERK2 in HeLa cells. We
first determined that siRNA-mediated knockdown of endoge-
nous ERK2 significantly de-repressed expression of IRF9 and
OAS1 (Figure 5I). However, in cells that lack endogenous
ERK2, overexpression of kinase-dead ERK2 repressed expres-
sion of IRF9 and OAS1 as efficiently as overexpression of wild-
type ERK2, whereas overexpression of DNA-binding-deficient
ERK2 did not show any significant effects (Figure 5I). These
results suggest that ERK2 plays an important role in regulating
expression of IFNg-induced genes via its DNA binding activity.
The above data suggest that low expression of IFNg-induced
genes might be maintained by the occupancy of ERK2 on the
promoters. Therefore, we predicted that promoter occupancy
of these genes by ERK2 might inversely correlate with induction
of gene expression in response to IFNg application. Using
a combination of quantitative ChIP and qRT-PCR, we measured
the dynamics of promoter occupancy by ERK2 and gene expres-
sion of IRF9 and OAS1. During the course of IFNg treatment we
observed that ERK2 was rapidly depleted from the promoters of
IRF9 and OAS1 within the first four hours and the ERK2 occu-
pancy reached its lowest level between 6 and 8 hr posttreatment.
Interestingly, promoter occupancy by ERK2 gradually rose and
almost fully recovered to its original level at 48 hr posttreatment.
As predicted, the mRNA level of both IRF9 and OAS1 shows
a near-perfect inverse correlation to promoter occupancy by
ERK2 (Figure 5J).
DISCUSSION
The identification of many sequence-specific PDIs for both
conventional TFs and uDBPs raises an interesting question;
that is whether these uDBPs bind to different target sequences
than do annotated TFs. While some proteins in the same func-
tional class were found to have preferred DNA-binding profiles
selective to that protein family, the overlap in the DNA motifs
recognized by the TFs and uDBPs is remarkable and substantial
(Figure S18), which suggests a complex landscape for human
PDI networks and possible crosstalk between TFs and uDBPs.
As an example, we found that ERK2 regulates expression of
IFNg-induced genes via binding to GATE element, which has
also been shown to be bound by C/EBP-b (Roy et al., 2000).
Our study suggests that a crosstalk between C/EBP-b and the
DNA-binding and kinase activities of ERK2 results in a negative
feedback loop to tightly control the temporal expression pattern
of IRF9 and OAS1 upon IFNg induction. Previously, Kalvakolanu
and colleagues showed that upon IFNg induction C/EBP-b is
phosphorylated by ERK1/2 to activate expression of the
GATE-driven genes (Roy et al., 2002). However, this model
does not explain upregulation of the GATE-driven genes when
only ERK2 is knocked down in cells (Huang et al., 2008) or the
suppression of IRF9 and OAS1 8 hr post IFNg-treatment (Fig-
ure 5J). Based on the discovered DNA binding activity of
ERK2, a plausible explanation is that expression of the GATE-
driven genes is dictated by competitive binding of C/EBP-b and
ERK2 to GATE element. In untreated cells, GATE is directly620 Cell 139, 610–622, October 30, 2009 ª2009 Elsevier Inc.bound by ERK2 via its DNA-binding domain and transcription
of the downstream genes is inhibited, which explains the upregu-
lation of those IFN-response genes when ERK2 is knocked down
(Huang et al., 2008).When cells are treatedwith IFNg, C/EBP-b is
rapidly induced and phosphorylated by ERK1/2, which are acti-
vated by the MEKK1/MEK1 pathway (Roy et al., 2002). The acti-
vated C/EBP-b in the nucleus then rapidly competes off ERK2
bound to GATE, resulting in a rapid activation of the GATE-driven
genes and a sharp decline of ERK2 occupancy at GATE (Fig-
ure 5J). As this proceeds, the concentration of nuclear ERK2
gradually increases to a level that it starts to compete off bound
C/EBP-b and therefore posts a negative feedback to eventually
shut down expression of these genes. Taken together, we
believe that the crosstalk between the two independent ERK2
activities and C/EBP-b partially explains the dynamics of IFNg-
induced gene expression.
A significant advantage of the presented protein-centered
approach is that the binding specificity of a given DNA motif
can be simultaneously measured for thousands of proteins in
a single assay. In our studies, we carefully selected DNA motifs
that are either highly conserved during evolution or highly en-
riched in the regulatory regions of coexpressed genes, and
thus likely to act to regulate transcription. Indeed, the fact that
virtually all of the DNA motifs tested in this study bound selec-
tively to proteins on the array suggests that these sequences
are indeed involved in regulating transcription in vivo. Further-
more, our approach can examine a large variety of protein
families, providing an opportunity to discover uncharacterized
DNA-binding proteins. It is expected that combined with gene-
centered approaches, such as protein-binding DNAmicroarrays
and one-hybrid analysis, we will be able to precisely determine
DNA binding consensus sequences for many uDBPs.
EXPERIMENTAL PROCEDURES
Probe Preparation
Double-stranded DNA probes were generated according to a protocol
described previously (Ho et al., 2006).
Human ORF Cloning
Using the Gateway recombinant cloning system (Invitrogen, CA), human ORFs
were shuttled from the selected entry clones of the Ultimate Human ORF
Collection (Invitrogen, CA) or from the entry clones generated in our own
laboratories to a yeast high-copy expression vector (pEGH-A) that produces
GST-His6 fusion proteins under the control of the galactose-inducible GAL1
promoter. Plasmids were rescued into E. coli and verified by restriction endo-
nuclease digestion. Plasmids with inserts of correct size were transformed into
yeast for protein purification.
Protein Purification
Human proteins were purified as GST-His6 fusion proteins from yeast using
a high-throughput protein purification protocol as described previously (Zhu
et al., 2001).
Protein Microarrays
Purified human proteins were arrayed in a 384-well format and printed on FAST
slides (Whatman, Germany) in duplicate. The protein microarrays were probed
with Cy5-labeled DNA motifs using a protocol similar to that previously
described (Ho et al., 2006): A protein chip was blocked for 3 hr with 3% BSA
in hybridization buffer (25 mMHEPES at pH 8.0, with 50 mMKGlu, 0.1% Triton
X-100, 8 mM MgAC2, 3 mM DTT, 4 mM poly [dA-dT], and 10% glycerol) and
then incubated with a Cy5-labeled DNA motif at a final concentration of 40 nM
in hybridization buffer at 4C overnight. The chip was washed once in cold
hybridization buffer without poly (dA-dT) for 5 min and spun to dryness. The
slides were finally scanned with a GenePix 4000 scanner (MDS Analytical
Technologies, CA) and the binding signals were acquired using the GenePix
software.
EMSAs
Each binding reaction was carried out with 100 fmol of biotinylated dsDNA
probe and 2 pmol of purified protein in 20 ml of binding buffer (25 mM HEPES
at pH 8.0 with 50 mM KGlu, 0.1% Triton X-100, 2 mMMgAC2, 3 mM DTT, and
5% glycerol). Twenty-five pmol (a 250-fold excess) of unlabeled (cold) DNA
motifs were added in the competition assays. Reactions were carried out for
30min at room temperature, followed by overnight incubation at 4C. Reaction
mixtures were loaded onto 5% TBE polyacrylamide gels and separated at
100 V on ice until the dye front migrated two-thirds of the way to the bottom
of the gel. Nucleic acids were transferred to nylon membranes and visualized
with the LightShift EMSA Kit (Pierce, USA) according to the manufacturer’s
recommendations. All the expression clones for proteins used in EMSA were
verified by DNA sequencing.
Luciferase Assays
Four tandem repeats of the DNA motif and the GATE element (Weihua et al.,
1997) were subcloned into pTK-Luc vector (McKnight et al., 1981) and pGL3
vector (Promega, USA), respectively. DNA was transfected using the Fuge-
neHD reagent (Roche, Switzerland). For the 43 DNA-motif, GT1-7 cells were
cotransfected with three constructs: pTK-Luc, pCAGIG expressing ERK2,
and pRL-TK (Promega, USA). For the GATE element, 3 hr after the transfection
of pGL3 construct, siRNA against 30UTR of ERK2 was tranfected using Trans-
Pass R1 reagent (NEB, USA). Cells were harvested 48 hr posttransfection for
luciferase reporter assay using the Dual-Luciferase reporter assay system
(Promega, USA). The luciferase activity was normalized by the internal control
pRL-TK Renilla luciferase activity. All assays were performed in three separate
experiments done in triplicate.
Chromatin Immunoprecipitation
Chromatin immunoprecipitation (ChIP) was carried out on HeLa cells using
a mouse anti-ERK2 antibody (Millipore, USA) or a rabbit anti-PCK2 antibody
(Santa Cruz, USA) according to a protocol described previously (Nelson
et al., 2006), except that the protein A-Sepharose was replaced with salmon
sperm DNA/protein A-agarose (Millipore, USA). Normal mouse or rabbit IgG
was used for mock IP as a negative control.
Site-Directed Mutagenesis
Site-directed mutagenesis was carried out using the QuikChange Multi Site-
Directed Mutagenesis Kit (Stratagene, USA) as described previously (Jensen
and Weilguny, 2005).
Computational Analysis
The tissue specific motifs were identified using algorithms previously
described (Yu et al., 2006), and see Supplemental Experimental Procedures
for details. The procedures of protein chip data analysis include image scan,
background correction, within-chip normalization, identification of positive
hits, and nonspecific binding filtering. Normalization and identification of posi-
tive hits were performed using the algorithms described in Supplemental
Experimental Procedures in detail. DNA-binding logos were discovered using
AlignACE (Roth et al., 1998). The DNA-binding logoswere aligned using the un-
gapped Smith-Waterman algorithm (Smith and Waterman, 1981). The clus-
tering tree of the TF logos was built using Neighbor-joint algorithm. The tree
was visualized using MEGA4 (Tamura et al., 2007). Potential DNA motifs in
the promoter regions were identified using MDscan (Liu et al., 2002). The
distance between the DNA-binding profiles of any two proteins in the phylo-
genetic tree is defined in Supplemental Experimental Procedures. The initial
phylogenetic tree was constructed based on the distance information using
the minimum evolution method in MEGA4. The length of the branches was
log-transformed. The curved layout was built manually. The length of the
branches was in some cases slightly altered when the curved layout was con-structed, and therefore the length was not precisely proportional to the actual
distances between binding profiles. P value of GO analysis was calculated
using one-sided Fisher exact test corrected for multiple testing using the
minimum P method of Westfall and Young (Westfall and Young, 1993) as
provided in Ontologizer (Bauer et al., 2008). ChIP-chip data was analyzed
using Cisgenome (Ji et al., 2008).
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experimental Procedures, 20
figures, 13 tables, and Supplemental References and can be found with this
article online at http://www.cell.com/supplemental/S0092-8674(09)01111-8.
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